Dena M. Carbonari

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance

Vincent Lo Re, Charitha Gowda, Paul Urick et al. · Clinical Gastroenterology and Hepatology · 2016 · 127 citations · Full text

Health Insurance Reform, Preventive Medicine, Health Policy +8

Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System

David S. Goldberg, Kimberly A. Forde, Dena M. Carbonari et al. · Gastroenterology · 2015 · 111 citations · Full text

Hepatology, Pharmacoepidemiology, Patient Safety +9

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

Vincent Lo Re, Dena M. Carbonari, James D. Lewis et al. · The American Journal of Medicine · 2015 · 90 citations · Full text

Antifungal Agent, Hepatology, Medicine +9

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study

Charitha Gowda, Stephen Lott, Matthew Grigorian et al. · Open Forum Infectious Diseases · 2018 · 74 citations · Full text

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients

Vincent Lo Re, Sarah K. Dutcher, John G. Connolly et al. · JAMA · 2022 · 74 citations · Full text